AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Merck & Co., Inc. (NYSE:MRK) 65 0 0
GlaxoSmithKline plc (ADR) (NYSE:GSK) 21 0 0
Bristol Myers Squibb Co. (NYSE:BMY) 43 0 0
AstraZeneca plc (ADR) (NYSE:AZN) 17 0 0
Eli Lilly & Co. (NYSE:LLY) 38 0 0

Using the results shown by Insider Monkey’s research, regular investors should always keep one eye on hedge fund and insider trading activity, and AbbVie Inc (NYSE:ABBV) applies perfectly to this mantra.

Discover how hedge fund piggybacking can benefit you

Page 2 of 2